EFFECTS OF ZAPRINAST ON RENAL NERVE STIMULATION-INDUCED ANTI-NATRIURESIS IN ANAESTHETIZED DOGS

SUMMARY 1. We examined whether zaprinast, a putative cGMP‐specific phosphodiesterase inhibitor, affects neural control of renal function in pentobarbital‐anaesthetized dogs. 2. Renal nerve stimulation (1Hz, 1ms duration) reduced urine flow rate, urinary Na+ excretion (UNaV) and fractional excretion...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental pharmacology & physiology Vol. 25; no. 12; pp. 1008 - 1012
Main Authors Sekizawa, Toshihiro, Shima, Yuichiro, Yoshida, Kozo, Tanahashi, Masayuki, Yoshida, Makoto, Suzuki-Kusaba, Mizue, Hisa, Hiroaki, Satoh, Susumu
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SUMMARY 1. We examined whether zaprinast, a putative cGMP‐specific phosphodiesterase inhibitor, affects neural control of renal function in pentobarbital‐anaesthetized dogs. 2. Renal nerve stimulation (1Hz, 1ms duration) reduced urine flow rate, urinary Na+ excretion (UNaV) and fractional excretion of Na+ (FENa) with little change in either renal blood flow (RBF) or glomerular filtration rate (GFR). 3. Intrarenal arterial infusion of zaprinast (10 and 100 μg/kg per min) increased basal urine flow rate, UNaV and FENa but not RBF or GFR. Zaprinast infusion (100 μg/kg per min) also increased renal venous plasma cGMP concentration and urinary cGMP excretion. 4. Renal nerve stimulation‐induced reductions in UNaV and FENa were attenuated during zaprinast infusion, whereas the reduction in urine flow rate was resistant to zaprinast. 5. Renal nerve stimulation increased the renal venous plasma noradrenaline concentration and renal noradrenaline efflux, which remained unaffected during infusion of zaprinast (100 μg/kg per min). 6. The results of the present study suggest that zaprinast induces natriuresis and counteracts adrenergically induced anti‐natriuresis by acting on renal tubular sites in the dog kidney in vivo.
Bibliography:istex:9FCB38A9F4A41975820806E1D1F9DCED23363593
ark:/67375/WNG-35SV5PBH-8
ArticleID:CEP1008
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0305-1870
1440-1681
DOI:10.1111/j.1440-1681.1998.tb02175.x